NCDP healthcare reform recommendations advocate for diabetes prevention, treatment and care
PRINCETON, N.J. The National Changing Diabetes Program, a program of Novo Nordisk, and several member associations urged President Obama and members of Congress to make the prevention, detection and treatment of diabetes, one of the nation’s most pervasive and costly diseases, a priority in reforming the U.S. healthcare system.
In an open letter to the President and lawmakers, NCDP said a national response to diabetes is required in order to transform health care and begin to ease the economic and personal burden of the disease, which is growing at an alarming rate. Today, more than 1-in-4 Americans have diabetes or pre-diabetes, and these two conditions are estimated to have cost the U.S. $218 billion in 2007 in medical care and lost productivity, according to a recent study.
Joining the NCDP in reaching out to lawmakers are the American Diabetes Association, the American College of Physicians and VSP.
“We applaud the effort to reorient our health care system to focus more on the prevention of disease, and nowhere is the need greater than with diabetes,” said Dana Haza, senior director of NCDP, an initiative created by Novo Nordisk to drive health systems change at the national and local level. “Not only does diabetes frequently result in devastating and costly complications, but diabetes also significantly increases the risk of heart disease, stroke, blindness, kidney disease, amputations and depression. So tackling diabetes early will make a huge impact on our nation’s overall health care system.”
The NCDP is calling on lawmakers to ensure diabetes is a top priority for health reform, including all new or expanded initiatives in public programs such as Medicare, Medicaid and CHIP. The organization said diabetes needs to be specifically identified as a priority condition for:
- Patient-centered care models
- Chronic care management programs
- Health information technology programs
- Programs to reduce racial and ethnic disparities in health care
- Prevention and health promotion initiatives
- Quality improvement initiatives
- Quality-based incentives
- Medicare and Medicaid demonstrations of new care models and delivery systems
“We are facing a unique opportunity to profoundly change health care in America and improve the lives of countless people,” Haza said. “Changing diabetes is essential to health care reform.”
Luna unveils product line with new vitamin D recipe
BERKELEY, Calif. In response to women’s ever-changing nutritional needs, Luna, the maker of the Whole Nutrition Bar for Women, announced a new Luna bar recipe with added vitamin D to help support women’s calcium absorption and promote more complete bone health.
Coinciding with Luna’s 10th anniversary, the new recipe commemorates a decade of nourishing women from the inside out. LUNA continues to provide women with the taste they love and the nutrition that their bodies crave.
“Luna has always been dedicated to staying current with the latest knowledge around women’s nutrition to ensure that our food continues to deliver on the nutrients women need most,” said Nicole Pemerl, brand manager of Luna. “The new recipe underscores our commitment to women’s nutrition.”
Luna’s new vitamin D recipe hits shelves this summer in all of the Luna flavors that women have come to love, including White Chocolate Macadamia, Lemon Zest and Nutz Over Chocolate. Each bar is 170 to 190 calories each, rich in antioxidants and high in folic acid, calcium and iron.
Improvita private-label item gets retailers in hot water
NEW YORK It’s a reminder that retailers are only one step removed from litigations involving one of their suppliers, especially when that supplier is manufacturing a store brand offering for them.
But perhaps more important, it may also be an indicator that like the Food and Drug Administration, the Federal Trade Commission may be a little more proactive in pursuing regulatory actions than they may have under the Bush administration. The FDA so far this year has issued more than 60 warning letters to dietary supplement companies making inappropriate treatment or prevention claims, and that’s just since the inauguration. It’s not as though the regulation isn’t clear — supplement companies cannot make claims that their products cure, mitigate or prevent any disease state. Though to be clear, many of the recent warning letters target online-only supplement distributors making such egregious claims as cancer prevention or a swine flu cure.
Dietary supplement manufacturers have already done quite a bit to shed an underserved reputation of shilling snake-oil-type products. The Council for Responsible Nutrition, for example, has funded increased advertising review by the National Advertising Division, a program that’s expected to receive additional funding going forward. The association has also become more aggressive of late in defending the industry by challenging critical news reports that base their criticisms on inaccuracies or faulty meta-analyses, and counter those criticisms with arguments grounded in science.